1. Home
  2. SOBR vs VIVS Comparison

SOBR vs VIVS Comparison

Compare SOBR & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.59

Market Cap

2.4M

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$0.41

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOBR
VIVS
Founded
2004
2007
Country
United States
United States
Employees
N/A
9
Industry
Newspapers/Magazines
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SOBR
VIVS
Price
$0.59
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.3M
4.8M
Earning Date
04-10-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
103.55
N/A
EPS
N/A
N/A
Revenue
$437,421.00
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
105.62
N/A
52 Week Low
$0.35
$0.41
52 Week High
$4.39
$5.30

Technical Indicators

Market Signals
Indicator
SOBR
VIVS
Relative Strength Index (RSI) 44.46 18.88
Support Level N/A N/A
Resistance Level $0.94 $2.21
Average True Range (ATR) 0.33 0.13
MACD -0.04 -0.03
Stochastic Oscillator 9.82 0.72

Price Performance

Historical Comparison
SOBR
VIVS

About SOBR SOBR Safe Inc.

Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: